Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors

Download All
Review recent developments with selective CDK4/6 inhibitors in the care of patients with various cancers in this text module, on-demand Webcast, and accompanying slideset developed by Richard Finn, MD; Geoffrey Shapiro, MD, PhD; and Gary K. Schwartz, MD.
Richard S. Finn, MD
Program Director
Gary K. Schwartz, MD
Geoffrey Shapiro, MD, PhD

On-Demand Webcast

In this Webcast from a satellite symposium at the 2017 annual meeting in Chicago, expert insights on the biology and emerging role of CDK4/6 inhibitors in multiple tumor types are provided by Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD.

Richard S. Finn, MD
Program Director
Gary K. Schwartz, MD Geoffrey Shapiro, MD, PhD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: July 13, 2017 Expired: No longer available for credit
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Pfizer, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings